ð¡ 2åç³å°¿ç ãšã¡ã¿ããªãã¯ã·ã³ãããŒã ããã¿ãã³DããããŠãã±ã¡ãªã³ãã®æå€ãªé¢ä¿ãšã¯ïŒ
çŸä»£ç€ŸäŒã«ãããŠã2åç³å°¿ç ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã¯ãå€ãã®äººã ãçŽé¢ããå¥åº·èª²é¡ã§ãããããã®ç æ ã¯ãå¿èç ãè³åäžãªã©ãããã«æ·±å»ãªç æ°ã®ãªã¹ã¯ãé«ããããšãç¥ãããŠããŸãããããããããã®ç æ°ã®èæ¯ã«ã¯ããŸã ååã«ç¥ãããŠããªãæ§ã ãªèŠå ãé ãããŠãããããããŸããã
ä»åã玹ä»ããç ç©¶ã¯ã2åç³å°¿ç æ£è ããã«ãããããã¿ãã³Dãã®ç¶æ ãšãããŸãèãæ £ããªããã±ã¡ãªã³ããšããç©è³ªããã¡ã¿ããªãã¯ã·ã³ãããŒã ã®çç¶ãšã©ã®ããã«é¢é£ããŠããã®ãã詳ãã調ã¹ããã®ã§ãããã®ç ç©¶ãéããŠãç§ãã¡ã®å¥åº·ãç¶æããããã«ãã©ã®ãããªç¹ã«æ³šæãã¹ãããèŠããŠããŸãã
ð¬ ã©ã®ããã«ç ç©¶ãããã®ãïŒïŒç ç©¶æ¹æ³ïŒ
ç ç©¶ã®èæ¯ãšç®ç
ãã¿ãã³Dã¯ã骚ã®å¥åº·ã ãã§ãªããå ç«æ©èœã代è¬ã«ãéèŠãªåœ¹å²ãæããããšãè¿å¹Žæ³šç®ãããŠããŸããäžæ¹ãã±ã¡ãªã³ã¯ãèèªçްèãªã©ããåæ³ãããççæŽ»æ§ç©è³ªïŒâ»1ïŒã§ãççãã€ã³ã¹ãªã³æµææ§ïŒâ»2ïŒã«é¢äžããå¯èœæ§ã瀺åãããŠããŸãã
æ¬ç ç©¶ã¯ã2åç³å°¿ç æ£è ãããšç³å°¿ç ã§ã¯ãªãæ¹ã ã«ãããŠãè¡äžã®ãã¿ãã³DïŒ25-ããããã·ãã¿ãã³D [25(OH)D]ïŒãšã±ã¡ãªã³ã®æ¿åºŠããã¡ã¿ããªãã¯ã·ã³ãããŒã ïŒMetSïŒïŒâ»3ïŒã®åæ§æèŠçŽ ïŒäžå¿æ§è¥æº/è ¹å²ãè¡å§ãç©ºè ¹æè¡ç³ãäžæ§èèªãHDLã³ã¬ã¹ãããŒã«ïŒãšã©ã®ããã«é¢é£ããŠããããæããã«ããããšãç®çãšããŸããã
â»1 ççæŽ»æ§ç©è³ªïŒäœå
ã§ç¹å®ã®ççæ©èœãæã€ç©è³ªã®ç·ç§°ã
â»2 ã€ã³ã¹ãªã³æµææ§ïŒã€ã³ã¹ãªã³ãååã«åæ³ãããŠããŠãããã®åããæªããªããè¡ç³å€ãäžããã«ãããªãç¶æ
ã
â»3 ã¡ã¿ããªãã¯ã·ã³ãããŒã ïŒMetSïŒïŒå
èèèªã®èç©ãèæ¯ã«ãé«è¡ç³ãé«è¡å§ãè質ç°åžžã®ãã¡2ã€ä»¥äžã䜵ãæã£ãç¶æ
ã
ç ç©¶ãã¶ã€ã³ãšåå è
ãã®ç ç©¶ã¯ãç¹å®ã®æç¹ã§ã®é¢é£æ§ã調ã¹ããæšªæçåæç ç©¶ãïŒâ»4ïŒãšããŠå®æœãããŸããã2021幎8æãã2022幎12æã«ãããŠãåèš176åã®åå è ãç ç©¶ã«ååããŸãããå èš³ã¯ã2åç³å°¿ç æ£è ãã88åãšãç³å°¿ç ã§ã¯ãªãæ¯èŒå¯Ÿè±¡è 88åã§ãã©ã¡ãã®ã°ã«ãŒããç·å¥³ã®äººæ°ã¯åçïŒå¥³æ§44åãç·æ§44åïŒã§ããã
â»4 暪æçåæç ç©¶ïŒããæç¹ã§ã®éå£ã®å¥åº·ç¶æ ãèŠå ã調æ»ãããããã®é¢é£æ§ãåæããç ç©¶ãæéã®çµéã«ããå æé¢ä¿ã¯çŽæ¥ç€ºããªãã
枬å®é ç®ãšè©äŸ¡
åå è ã®è¡äžããã¯ããã¿ãã³Dã®ç¶æ ã瀺ãäž»èŠãªææšã§ãã25(OH)Dãã±ã¡ãªã³ããããŠççããŒã«ãŒã§ããCRPïŒâ»5ïŒããELISAæ³ïŒâ»6ïŒãšããæ¹æ³ã§æž¬å®ãããŸããããŸããã¡ã¿ããªãã¯ã·ã³ãããŒã ã®èšºæã¯ãåœéç³å°¿ç é£åïŒIDFïŒïŒâ»7ïŒã®åºæºã«åºã¥ããŠè¡ãããŸããããã¿ãã³Dã®ç¶æ ããè¡äžæ¿åºŠã«å¿ããŠãæ¬ ä¹ããäžè¶³ããååãã®3段éã«åé¡ãããŸããã
â»5 CRPïŒCåå¿æ§ã¿ã³ãã¯ïŒïŒäœå
ã§ççãèµ·ããŠãããšãã«å¢å ããã¿ã³ãã¯è³ªã§ãççã®æç¡ãçšåºŠã瀺ãããŒã«ãŒã
â»6 ELISAæ³ïŒé
µçŽ å
ç«æž¬å®æ³ïŒïŒæäœãšé
µçŽ åå¿ãå©çšããŠãè¡æ¶²äžã®ç¹å®ã®ç©è³ªïŒã¿ã³ãã¯è³ªãªã©ïŒã®éãæž¬å®ããæ¹æ³ã
â»7 åœéç³å°¿ç
é£åïŒIDFïŒïŒç³å°¿ç
ã«é¢ããåœéçãªçµç¹ã§ãç³å°¿ç
ã®äºé²ãæ²»çãã±ã¢ã«é¢ããã¬ã€ãã©ã€ã³ãæ
å ±ãæäŸããŠããã
ð ç ç©¶ããèŠããŠããäž»ãªãã€ã³ã
ãã®ç ç©¶ã§åŸãããäž»èŠãªçµæããåããããã衚ã«ãŸãšããŸããã
| é ç® | 2åç³å°¿ç æ£è ã°ã«ãŒã | éç³å°¿ç æ¯èŒã°ã«ãŒã | çµ±èšçææå·® (på€) | äž»ãªãã€ã³ã |
|---|---|---|---|---|
| è¡äžã±ã¡ãªã³æ¿åºŠ | ææã«é«ã | äœã | p < 0.001 | 2åç³å°¿ç æ£è ã§ã±ã¡ãªã³ãé«ã |
| è¡äž25(OH)Dæ¿åºŠ | ææã«äœã | é«ã | p < 0.001 | 2åç³å°¿ç æ£è ã§ãã¿ãã³Dãäœã |
| ã¡ã¿ããªãã¯ã·ã³ãããŒã ã®æç ç | 79.5% (70/88å) | 48.9% (43/88å) | p < 0.001 | 2åç³å°¿ç æ£è ã§MetSã®å²åãé«ã |
| ãã¿ãã³Dæ¬ ä¹ç | 20.5% (18/88å) | 8% (7/88å) | p < 0.001 | 2åç³å°¿ç æ£è ã§ãã¿ãã³Dæ¬ ä¹ãå€ã |
| ãã¿ãã³Däžè¶³ç | 53.4% (47/88å) | 36.4% (32/88å) | p < 0.001 | 2åç³å°¿ç æ£è ã§ãã¿ãã³Däžè¶³ãå€ã |
ããã«ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®æç¡ã«ããæ¯èŒã§ã¯ãã¡ã¿ããªãã¯ã·ã³ãããŒã ãããäººã®æ¹ãããªãäººã«æ¯ã¹ãŠè¡äžã±ã¡ãªã³ã¬ãã«ãé«ãããšã瀺ãããŸãã (p = 0.032)ã
2åç³å°¿ç æ£è ã°ã«ãŒãå ã§ã®è©³çްãªé¢é£æ§
- ãã¿ãã³D (25(OH)D) ãšã®é¢é£
- ç©ºè ¹æè¡ç³ (FPG)ïŒâ»8ïŒãã€ã³ã¹ãªã³ãã€ã³ã¹ãªã³æµææ§ã®ææš (HOMA-IR)ïŒâ»9ïŒããã¢ã°ããã³A1c (HbA1c)ïŒâ»10ïŒãç·ã³ã¬ã¹ãããŒã« (TC)ïŒâ»11ïŒãCRPïŒççããŒã«ãŒïŒãé«ãã»ã©ã25(OH)Dã¬ãã«ãäœããšããéã®é¢é£ãèŠãããŸããã
- ãã®éã®é¢é£ã¯ãã¡ã¿ããªãã¯ã·ã³ãããŒã ãæã€ãµãã°ã«ãŒãå ã§ãåæ§ã«èгå¯ãããŸããã
- ã±ã¡ãªã³ãšã®é¢é£
- ã€ã³ã¹ãªã³æµææ§ã®ææš (HOMA-IR)ãç©ºè ¹æè¡ç³ (FPG)ãç·ã³ã¬ã¹ãããŒã« (TC)ãCRPããã¢ã°ããã³A1c (HbA1c) ãšã±ã¡ãªã³ã®éã«ã¯é¢é£ãèŠãããŸããã
- ã¡ã¿ããªãã¯ã·ã³ãããŒã ãæã€ãµãã°ã«ãŒãå ã§ã¯ãç©ºè ¹æè¡ç³ (FPG)ãã€ã³ã¹ãªã³ãã€ã³ã¹ãªã³æµææ§ã®ææš (HOMA-IR)ããã¢ã°ããã³A1c (HbA1c)ãç·ã³ã¬ã¹ãããŒã« (TC)ãCRPãšã±ã¡ãªã³ã®éã«æ£ã®çžé¢ïŒäžæ¹ãé«ããšããäžæ¹ãé«ãé¢ä¿ïŒãç¶æãããŠããŸããã
ç¬ç«ããé¢é£æ§
- çµ±èšçãªè§£æã®çµæã25(OH)Dã®ç¶æ ã«ã¯ãç³å°¿ç ã§ããããšããšã女æ§ã§ããããšããç¬ç«ããŠé¢é£ããŠããããšãæããã«ãªããŸããã
- ã±ã¡ãªã³ãš25(OH)Dã®éã«ã¯ãã±ã¡ãªã³ãé«ãã»ã©25(OH)Dãäœããšãããéã®ææãªé¢é£ã確èªãããŸããã
- ã¡ã¿ããªãã¯ã·ã³ãããŒã ã®ç¶æ ã«ã¯ããç³å°¿ç ã§ããããšããšã女æ§ã§ããããšãã®ã¿ãç¬ç«ããŠé¢é£ããŠããŸããããã¿ãã³Dãã±ã¡ãªã³ã¯ãä»ã®èŠå ã調æŽããåŸã®ã¢ãã«ã§ã¯ãã¡ã¿ããªãã¯ã·ã³ãããŒã ãšç¬ç«ããé¢é£ã¯ç€ºããŸããã§ããã
â»8 空è
¹æè¡ç³ (FPG)ïŒé£äºãããäžå®æéçµéããåŸã®è¡ç³å€ã
â»9 HOMA-IRïŒHomeostasis Model Assessment of Insulin ResistanceïŒïŒç©ºè
¹æè¡ç³ãšç©ºè
¹æã€ã³ã¹ãªã³å€ããç®åºããããã€ã³ã¹ãªã³æµææ§ã®ææšã
â»10 ãã¢ã°ããã³A1c (HbA1c)ïŒéå»1ïœ2ã¶æéã®è¡ç³å€ã®å¹³åçãªç¶æ
ãç€ºãææšã
â»11 ç·ã³ã¬ã¹ãããŒã« (TC)ïŒè¡æ¶²äžã®ã³ã¬ã¹ãããŒã«å
šäœã®éã
ð€ ç ç©¶çµæã®èå¯
2åç³å°¿ç æ£è ã«ããããã¿ãã³Dãšã±ã¡ãªã³ã®ç¹åŸŽ
ãã®ç ç©¶ã¯ã2åç³å°¿ç æ£è ããããç³å°¿ç ã§ã¯ãªã人ã ã«æ¯ã¹ãŠãè¡äžã®ãã¿ãã³Dæ¿åºŠãäœããã±ã¡ãªã³æ¿åºŠãé«ãããšãæç¢ºã«ç€ºããŸããããã¿ãã³Dã®äžè¶³ã¯ãã€ã³ã¹ãªã³ã®åããæªãããããäœå ã®ççãä¿é²ãããããå¯èœæ§ãææãããŠããŸããäžæ¹ãã±ã¡ãªã³ã®å¢å ã¯ãèèªçµç¹ã®æ©èœäžå šãççã®æªåãšé¢é£ããŠãããšèããããŠããŸãã
ãããã®çµæã¯ã2åç³å°¿ç ãšããç æ ããåã«è¡ç³å€ãé«ãã ãã§ãªãããã¿ãã³Dã®ä»£è¬ç°åžžãã±ã¡ãªã³ã®ãããªççæŽ»æ§ç©è³ªã®ãã©ã³ã¹ã®ä¹±ãã䌎ã£ãŠããå¯èœæ§ã瀺åããŠããŸããç¹ã«ããã¿ãã³Dã®æ¬ ä¹ãäžè¶³ã2åç³å°¿ç æ£è ããã«å€ãèŠãããããšã¯ããã®æ é€çŽ ã®è£çµŠãç æ 管çã«ãããŠéèŠã§ããå¯èœæ§ã瀺åããŠããŸãã
ã¡ã¿ããªãã¯ã·ã³ãããŒã ãšã®é¢é£
ã¡ã¿ããªãã¯ã·ã³ãããŒã ãæã€äººã ã§ã±ã¡ãªã³æ¿åºŠãé«ããšããçµæã¯ãã±ã¡ãªã³ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®é²è¡ãæªåã«é¢äžããŠããå¯èœæ§ã瀺åããŠããŸããã±ã¡ãªã³ã¯ãèèªçµç¹ã®ççãä¿é²ããã€ã³ã¹ãªã³æµææ§ãé«ããããšã§ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®åæ§æèŠçŽ ïŒè¥æºãé«è¡ç³ãé«è¡å§ãè質ç°åžžïŒã«åœ±é¿ãäžãããšèããããŸãã
ããããçµ±èšçãªèª¿æŽãè¡ã£ãåŸã§ã¯ããã¿ãã³Dãã±ã¡ãªã³ãã¡ã¿ããªãã¯ã·ã³ãããŒã ãšç¬ç«ããŠé¢é£ããŠãããšã¯èšããŸããã§ãããããã¯ããã¿ãã³Dãã±ã¡ãªã³ãçŽæ¥çã«ã¡ã¿ããªãã¯ã·ã³ãããŒã ãåŒãèµ·ããããããã¯èšºæã®æ±ºãæãšãªãããã§ã¯ãªãããšãæå³ããŸãããããããããã®ç©è³ªã¯ã2åç³å°¿ç ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®èæ¯ã«ãããå¿è¡ç®¡ä»£è¬é害ãïŒâ»12ïŒ</small;ãšãããããåºç¯ãªå¥åº·åé¡ãšé¢é£ããŠãããããŒã«ãŒããšããŠæããã¹ãã ãšããèŠè§£ã瀺ãããŠããŸãã
â»12 å¿è¡ç®¡ä»£è¬é害ïŒå¿èãè¡ç®¡ã®ç æ°ãšãç³å°¿ç ãè¥æºãªã©ã®ä»£è¬ç°åžžãè€åçã«é¢é£ããå¥åº·åé¡ã
女æ§ãšç³å°¿ç ç¶æ ã®åœ±é¿
ãç³å°¿ç ã§ããããšããšã女æ§ã§ããããšããããã¿ãã³Dã®ç¶æ ã«ç¬ç«ããŠé¢é£ããŠãããšããçµæãè峿·±ãç¹ã§ããããã¯ãç³å°¿ç æ£è ãããç¹ã«å¥³æ§ã«ãããŠããã¿ãã³Dã®äžè¶³ãããé¡èã§ããå¯èœæ§ã瀺åããŠããŸãã女æ§ãã«ã¢ã³ã®åœ±é¿ãçæŽ»ç¿æ £ã®éããªã©ããããªãç ç©¶ãå¿ èŠãªé åã§ãã
ð¡ ç§ãã¡ã®å®ç掻ã«ã©ã掻ããïŒïŒå®ç掻ã¢ããã€ã¹ïŒ
ãã®ç ç©¶çµæã¯ãç§ãã¡ã®æ¥åžžç掻ã«ãããŠãç¹ã«2åç³å°¿ç ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®ãªã¹ã¯ãããæ¹ã ã«ãšã£ãŠãããã€ãã®éèŠãªç€ºåãäžããŠãããŸãã
- ãã¿ãã³Dã®æåãæèããŸããã
- ãã¿ãã³Dã¯ãæ¥å ãæµŽã³ãããšã§ç®èã§çæãããŸããé©åºŠãªæ¥å æµŽïŒæ¥äžã®çãæéãé¡ãè ãªã©ã«çŽæ¥æ¥å ãåœãŠãïŒãå¿ãããŸãããã
- é£äºãããæåã§ããŸãããµã±ããã°ããã«ããªãªã©ã®éé¡ããããã³é¡ïŒç¹ã«å¹²ãã·ã€ã¿ã±ïŒã«å€ãå«ãŸããŠããŸãã
- é£äºãæ¥å 济ã ãã§ã¯äžè¶³ããã¡ãªå Žåã¯ãå»åž«ãè¬å€åž«ãšçžè«ã®äžããµããªã¡ã³ãã®å©çšãæ€èšã§ããŸããç¹ã«ã2åç³å°¿ç æ£è ããã女æ§ã¯ããã¿ãã³Däžè¶³ã®ãªã¹ã¯ãé«ãå¯èœæ§ããããŸãã
- ã¡ã¿ããªãã¯ã·ã³ãããŒã ã®äºé²ãšç®¡ç
- ãã©ã³ã¹ã®åããé£äºãå¿ãããç¹ã«å å·¥é£åãç³åã®å€ãé£åã®æåãæ§ããŸããããéèãæç©ãå šç²ç©ç©ãè¯è³ªãªã¿ã³ãã¯è³ªãç©æ¥µçã«åãå ¥ããŸãããã
- 宿çãªéåã¯ãã€ã³ã¹ãªã³æµææ§ãæ¹åããäœé管çã«ã圹ç«ã¡ãŸãããŠã©ãŒãã³ã°ããžã§ã®ã³ã°ãæ°Žæ³³ãªã©ãç¡çãªãç¶ããããéåãèŠã€ããŸãããã
- 驿£äœéã®ç¶æã¯ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®äºé²ã»æ¹åã«äžå¯æ¬ ã§ããè ¹å²ãæèããå èèèªã®èç©ãé²ããŸãããã
- 宿çã«å¥åº·èšºæãåããè¡ç³å€ãè¡å§ãè質ãªã©ã®æ°å€ãææ¡ããç°åžžãããã°æ©æã«å»åž«ã«çžè«ããŸãããã
- å°éå®¶ãšã®é£æº
- ãèªèº«ã®å¥åº·ç¶æ ãç ç¶ã«åãããŠãå»åž«ãç®¡çæ é€å£«ã«çžè«ããé©åãªã¢ããã€ã¹ãåããããšãéåžžã«éèŠã§ããèªå·±å€æã§ãµããªã¡ã³ãã倧éã«æåããããæ¥µç«¯ãªé£äºå¶éãè¡ã£ããããããšã¯é¿ããŸãããã
ð§ ç ç©¶ã®éçãšä»åŸã®èª²é¡
æ¬ç ç©¶ã¯ã2åç³å°¿ç æ£è ã«ããããã¿ãã³Dãšã±ã¡ãªã³ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®é¢é£æ§ã瀺ã貎éãªç¥èŠãæäŸããŸããããããã€ãã®éçãååšããŸãã
- 暪æç ç©¶ã®éç
- ãã®ç ç©¶ã¯ç¹å®ã®æç¹ã§ã®ããŒã¿ãåæãããæšªæç ç©¶ãã§ããããããã¿ãã³Dãã±ã¡ãªã³ã®æ¿åºŠãäœãããšãã2åç³å°¿ç ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®åå ã§ããããããã¯ãã®éã§ãããšãã£ããå æé¢ä¿ããçŽæ¥çã«èšŒæããããšã¯ã§ããŸãããåã«ããããã®èŠçŽ ãåæã«ååšããŠãããšãããé¢é£æ§ãã瀺ããŠããã«éããŸããã
- ä»åŸã®ç ç©¶ã®å¿
èŠæ§
- ãã®é¢é£æ§ãæéãšãšãã«ã©ã®ããã«å€åããã®ãã远跡ããã瞊æç ç©¶ããããã¿ãã³Dã®è£çµŠã2åç³å°¿ç ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®æ¹åã«ç¹ããããæ€èšŒãããä»å ¥ç ç©¶ããä»åŸå¿ èŠãšãããŠããŸãã
- ã±ã¡ãªã³ãå¿è¡ç®¡ä»£è¬é害ã«ã©ã®ããã«é¢äžããŠããã®ãããã®è©³çްãªã¡ã«ããºã ãããã«è§£æããããšããä»åŸã®éèŠãªèª²é¡ã§ãã
â ãŸãšã
ãã®ç ç©¶ã¯ã2åç³å°¿ç æ£è ããã«ãããŠãè¡äžã®ãã¿ãã³Dæ¿åºŠãäœããã±ã¡ãªã³æ¿åºŠãé«ãããšããããŠããããã¡ã¿ããªãã¯ã·ã³ãããŒã ã®çç¶ãå¿è¡ç®¡ä»£è¬é害ãšé¢é£ããŠããå¯èœæ§ã瀺ããŸãããç¹ã«ã2åç³å°¿ç æ£è ããã§ã¯ãã¿ãã³Dã®æ¬ ä¹ãäžè¶³ãé¡èã§ãããã±ã¡ãªã³ã®å¢å ã芳å¯ãããŸããããããã®çºèŠã¯ã2åç³å°¿ç ãã¡ã¿ããªãã¯ã·ã³ãããŒã ã®ç®¡çã«ãããŠããã¿ãã³Dã®ç¶æ ãã±ã¡ãªã³ã®ãããªççæŽ»æ§ç©è³ªã®ãã©ã³ã¹ãèæ ®ããããšã®éèŠæ§ã瀺åããŠããŸãã ä»åŸã®ãããªãç ç©¶ã«ãã£ãŠããããã®é¢é£æ§ãããæ·±ãè§£æãããæ°ããªäºé²æ³ãæ²»çæ³ã®éçºã«ç¹ããããšãæåŸ ãããŸãã
ð é¢é£ãªã³ã¯é
- æ¥æ¬ç³å°¿ç åŠäŒ
- åçåŽåç
- åœç«å¥åº·ã»æ é€ç ç©¶æ – ã¡ã¿ããªãã¯ã·ã³ãããŒã
- åœç«åŸªç°åšç ç ç©¶ã»ã³ã¿ãŒ
- International Diabetes Federation (åœéç³å°¿ç é£å)
æžèªæ å ±
| DOI | 10.3389/fmed.2026.1907839 |
|---|---|
| PMID | 42630215 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42630215/ |
| çºè¡å¹Ž | 2026 |
| èè å | Baig Mukhtiar, Gazzaz Zohair Jamil, Khabaz Mohamad Nidal, Abualhamael Shahad Abduljalil, Alzahrani Sami Hamdan, Alamoudi Wail A |
| èè æå± | Department of Clinical Biochemistry and Medical Education, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.; Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.; Department of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.; Department of Family Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. |
| éèªå | Front Med (Lausanne) |